Hsiao, P., Hsieh, K., Chen, Y., Hsu, C., Lo, G., Li, Y., . . . Lin, C. (2019). Sorafenib with concurrent multiple-line therapies improves overall survival in advanced stage hepatocellular carcinoma. Medicine (Baltimore).
Παραπομπή Chicago StyleHsiao, Pojen, et al. "Sorafenib With Concurrent Multiple-line Therapies Improves Overall Survival in Advanced Stage Hepatocellular Carcinoma." Medicine (Baltimore) 2019.
Παραπομπή MLAHsiao, Pojen, et al. "Sorafenib With Concurrent Multiple-line Therapies Improves Overall Survival in Advanced Stage Hepatocellular Carcinoma." Medicine (Baltimore) 2019.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.